Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Vivorx Pharmaceuticals (AKA: Vivorx Inc~American Bioscience)
Profile last edited on: 10/5/07      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1994
First Award
1994
Latest Award
1996
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2825 Santa Monica Boulevard
Santa Monica, CA 90404
   (310) 264-7768
   N/A
   N/A
Location: Single
Congr. District: 33
County: Los Angeles

Public Profile

VivoRx, a Santa Monica-based biopharmaceutical company, whose mission is to develop cell-therapeutic products for disease states for which no current effective therapy exists

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$461,914
Phase II Dollars
$0
Total Awarded
$461,914

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
50-74

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1996 1 NIH $95,582
Project Title: Rechargeable Cell Containment Device--Pancreatic Islet
1996 1 NIH $99,250
Project Title: HB Microbubbles As An Artificial RBC Substitute
1995 1 NIH $96,500
Project Title: Islets Encapsulated in Photopolymerizable Alginate
1995 1 NIH $95,582
Project Title: Rechargeable Cell Containment Device--Pancreatic Islet
1994 1 NIH $75,000
Project Title: Encapsulated Porcine Islets as a Bioartificial Pancreas

Key People / Management

  Neil Desai

  Richard E Hoffer

  Paul A Sandford

  Patrick Soon-Shiong

  Syed Yousuf Zafar

Company News

There are no news available.